key: cord-0749511-d118to5c
authors: Wang, Linghang; Liu, Yao; Zhang, Ting; Jiang, Yuyong; Yang, Siyuan; Xu, Yanli; Song, Rui; Song, Meihua; Wang, Lin; Zhang, Wei; Han, Bing; Yang, Li; Fan, Ying; Cheng, Cheng; Wang, Jingjing; Xiang, Pan; Pu, Lin; Xiong, Haofeng; Li, Chuansheng; Zhang, Ming; Tan, Jianbo; Chen, Zhihai; Liu, Jingyuan; Wang, Xianbo
title: Differentiating between 2019 novel coronavirus pneumonia and influenza using a non-specific laboratory marker-based dynamic nomogram
date: 2020-05-16
journal: Open Forum Infect Dis
DOI: 10.1093/ofid/ofaa169
sha: 49899785994a27e28ff79253936fad39a7d6b986
doc_id: 749511
cord_uid: d118to5c

BACKGROUND: There is currently a lack of non-specific laboratory indicators as a quantitative standard to distinguish between the 2019 coronavirus disease (COVID-19) and an influenza A or B virus infection. Thus, the aim of this study was to establish a nomogram to detect COVID-19. METHODS: A nomogram was established using data collected from 457 patients (181 with COVID-19 and 276 with influenza A or B infection) at China. The nomogram used age, lymphocyte percentage, and monocyte count to differentiate COVID-19 from influenza. RESULTS: Our nomogram predicted probabilities of COVID-19 with an AUROC of 0.913 (95% confidence interval [CI], 0.883–0.937), greater than that of the lymphocyte-to-monocyte ratio (0.849, 95%CI, 0.812–0.880; p = 0.0007), lymphocyte percentage (0.808, 95%CI, 0.768–0.843; p < 0.0001), monocyte count (0.780, 95%CI, 0.739–0.817; p < 0.0001), or age (0.656, 95%CI, 0.610–0.699; p < 0.0001). The predicted probability conformed to the real observation outcomes of COVID-19, according to the calibration curves. CONCLUSIONS: We found that age, lymphocyte percentage, and monocyte count are risk factors for the early-stage prediction of patients infected with the 2019 novel coronavirus. As such, our research provides a useful test for doctors to differentiate COVID-19 from influenza.

On 8 December 2019, an individual from the Huanan seafood market in Wuhan, China, was admitted to the hospital after having a fever, cough, and dyspnea for 7 days. Five days later, his wife, who had not been to the seafood market, was admitted to the hospital with pneumonia of unknown etiology. By 2 January 2020, 41 hospital patients had been admitted owing to pneumonia, which laboratory tests confirmed had resulted from an infection with the 2019 novel coronavirus [1] . This novel coronavirus has become a hot topic in the media and in research. However, the influenza virus, another infectious disease, is also a heavy burden on public health worldwide.

Two disparate genera of the virus family Orthomyxoviridae, influenza A and B, also manifest as contagious respiratory diseases in infected individuals [2] . Influenza virus normally propagates during the cold season in temperate areas [3] . Pandemics of seasonal influenza have appeared every 20 to 30 years, generally accompanied by serious symptoms, which could have a detrimental effect on the development of young people and result in increased mortality rates [4] [5] [6] . At present, a COVID-19 infection is diagnosed using real-time polymerase chain reaction (RT-PCR), which is time-consuming (It takes approximately 6 hours for an RT-PCR technician to complete the assay), and not available everywhere [7] . The detection rate of a virus' nucleic acids cannot be fully confirmed, and the nucleic acid detection of COVID-19 is no exception.

In addition to this, false negative results are practically inevitable. According to a recent research report from China, the detection rate of SARS-COV2-RNA is approximately 50% depending on the stage of the disease, the location of sample collection (upper or lower respiratory tract), the extent of sample RNA degradation, and the different extraction reagents used [8] . In addition, the incubation period of the new coronavirus is 1-14 days, extending even specimens. The former is more frequently used as it is quick, simple, and inexpensive; however, the large number of false-negatives resulting from this test is problematic [9] . During a disease outbreak, the amount of time needed to obtain a result can exceed the optimal time frame allowed for diagnosis, resulting in the use of tests incorporating non-specific indicators or surrogate influenza markers, while the outcome of the PCR diagnosis is being processed. These markers include relative lymphopenia, monocytosis, thrombocytopenia, and the lymphocytemonocyte ratio (LMR) [10] [11] [12] . However, there are currently no non-specific laboratory markers for COVID-19 in outpatients during epidemics of influenza A or B.

We conducted a retrospective single-center study. 

Age is presented as the median (range), categorical variables are arranged by number, and continuous variables are presented as mean (interquartile range). A comparison of the differences between the two groups was performed using the t-test, chi-square test, or Mann-Whitney U-test. A multivariable logistic regression analysis was used for the selection of variables that may differentiate COVID-19 from influenza. We then tested the linearity between logitP and these continuous variables. The statistical package SPSS 22.0 (SPSS, Inc., Chicago, IL, USA) was used to analyze the related information. A dynamic nomogram was generated using the DynNom package in R (version 3.0.2; R Foundation for Statistical Computing, Vienna, Austria). The predictive accuracy of the nomogram model was measured using the area under the receiver operating characteristic (AUROC) and calibration curves and the RMS packages with 1000 resample bootstraps. A p-value <0.05 (two-tailed) was considered statistically significant.

A summary of the demographic characteristics of the patients in the COVID-19 (n = 181) and influenza (n = 276) groups are provided in Table 1 . The median age of the two groups was A c c e p t e d M a n u s c r i p t 8 statistically different (p < 0.0001). The COVID-19 group had a median age of 38 years, whereas the median age of the influenza group was 29 years (Figure 1 ). No significant differences were observed between the two groups in terms of gender (p = 0.686). The non-specific laboratory tests showed that the WBC, NC, MC, and neutrophil-to-lymphocyte ratio (NLR) values in the influenza group were significantly higher than those in the COVID-19 group, where the LC, L%, and LMR values in the influenza group were significantly lower (p < 0.0001). The results of the multivariable logistic regression analysis demonstrated that age, L%, and MC were predictive non-specific laboratory markers for COVID-19 (Table 1) .

Based on the significant predictive non-specific laboratory markers selected using the logistic regression model, a dynamic nomogram was created for the prediction of COVID-19 probabilities ( Figure 2 ). This online tool (https://bjdth.shinyapps.io/COVID-19/) can be used to determine the risk of infection by COVID-19 by inputting the age (years), and lymphocyte percentage (%) and monocyte count (×10 9 /L) values of the corresponding outpatients.

Using the ROC curves, the predictive value of the nomogram model for the probabilities of COVID-19 and the single marker, according to the values for ae, L%, and MC, could be compared. Moreover, the predictive value of the nomogram was compared to that of the previously reported marker, LMR. As shown in Figure 3 , the developed nomogram model The calibration curves demonstrated that the predictive probability of the nomogram conformed to real results observed for COVID-19 ( Figure 4 ). As shown in Figure 5 , the predictive risk conformed to the observed outcome of frequency in most of the risk ranges. The X axis represents the COVID-19 probability groups (% range), and the y-axis represents the probabilities of COVID-19. The red histogram represents the predicted probability of COVID-19, and the blue histogram represents the observed probability of COVID-19.

At the beginning of the epidemic, nucleic acid testing was considered the gold standard for the diagnosis of the novel coronavirus pneumonia. However, previous data show that the success rate of nucleic acid testing is not high; moreover, there have recently been strict restrictions imposed on the conditions for the collection of specimens. To avoid these limitations and improve the accuracy of the test, the 6 th version of the new coronavirus pneumonia diagnosis and treatment plan (http://www.nhc.gov.cn/) states that, in addition to upper respiratory tract and blood samples, stool samples can also be used for diagnosis, if they are positive. It is hoped A c c e p t e d M a n u s c r i p t 10 that these types of amendments will improve the sensitivity of nucleic acid detection and allow a more accurate diagnosis. At present, the approaches used for the detection of the novel coronavirus pneumonia are divided into two categories: direct detection and indirect detection.

Direct detection comprises the detection of the nucleic acids of the novel coronavirus [13, 14] using RT-PCR or sequencing of the viral gene, which is highly homologous to known novel coronavirus [15] . In contrast, antibody and antigen tests represent the indirect detection tests [16] .

Although antibody detection has advantages in terms of convenience and speed, it is not currently able to replace the method of nucleic acid detection. Although CT detection can be used as an auxiliary method to achieve full coverage, it cannot completely distinguish between the novel coronavirus pneumonia and other pneumonias owing to the diverse manifestations of the pneumonia caused by the novel coronavirus [17] .

These diagnostic methods can give rise to both false negative or false positive results. There is currently a lack of non-specific laboratory indicators available for use as a quantitative standard.

Therefore, the identification of effective clinical indicators is particularly important to improve the accuracy of diagnosis.

In this study, data from 181 patients with COVID-19 and 276 patients with influenza were analyzed and the characteristics of the patients in the two groups were compared. The independent risk factors predicting COVID-19 were screened. The results revealed that age, L%, and MC had a significant predictive value. Based on these three variables, we established a dynamic nomogram to differentiate COVID-19 from influenza A or B. The distinguishing value of the nomogram was greater than that of LMC, L%, MC, or age alone. The nomogram A c c e p t e d M a n u s c r i p t 11 developed here allows COVID-19 to be reasonably predicted based on the patient's age and non-specific laboratory results, permitting rapid and straightforward diagnosis. This tool is readily available online and can be utilized freely by the public.

This study contained some limitations. Firstly, this study was single centered and did not have any external validation cohort. Secondly, we were unable to obtain the complete baseline characteristics for the majority of patients with influenza A or B virus infection. However, despite these limitations, according to the basic demographic indicators and non-specific laboratory indicators, this study established a good predictive model to assist in clinically differentiating COVID-19 infections from influenza A or B infections.

In Conclusion, the nomogram presented in this study is based on age, L%, and MC. This model was established to differentiate between COVID-19 and influenza A or B infections in outpatients. The results of a discrimination ability analysis demonstrated the high performance of the nomogram developed in this study. 

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Human Influenza Virus Infections. Seminars in respiratory and critical care medicine

Influenza virus transmission is dependent on relative humidity and temperature

The origin and virulence of the 1918 "Spanish" influenza virus

The signature features of influenza pandemics--implications for policy

Pediatric hospitalizations due to influenza in 2010

Chinese Association of Chest Physicians. Guide for the prevention and treatment of coronavirus disease 2019

A (H1N1) virus in humans

Relative lymphopenia and monocytosis may be considered as a surrogate marker of pandemic influenza a (H1N1)

Before influenza tests results are available, can droplet precautions be instituted if influenza is suggested by leukopenia, relative lymphopenia, or thrombocytopenia?

The clinical usefulness of lymphocyte:monocyte ratios in differentiating influenza from viral non-influenza-like illnesses in hospitalized adults during the 2015 influenza A (H3N2) epidemic: the uniqueness of HPIV-3 mimicking influenza A

European journal of clinical microbiology & infectious diseases: official publication of the

Development of Genetic Diagnostic Methods for Novel Coronavirus 2019 (nCoV-2019) in Japan

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro surveillance : bulletin Europeen sur les maladies transmissibles

RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak

Recent advances in the detection of respiratory virus humans

Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China

None.

A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t